BioCurex Inc. Presents RECAF Point-of-Care Test Results At International Cancer Congress

RICHMOND, British Columbia, Sept. 18, 2007 (PRIME NEWSWIRE) -- BioCurex, Inc. (OTCBB:BOCX) announced today a presentation to the International Society for Oncodevelopmental Biology and Medicine (ISOBM). The presentation documents a study conducted by BioCurex in its development of a ‘rapid test’ for ambulatory cancer detection, based on its patented RECAF(tm) cancer marker. This study was conducted in conjunction with the Blokhin Cancer Research Centre, Moscow, Russia.

MORE ON THIS TOPIC